NAV
34.18(-0.93%)Fund Size (CR)
₹853.63Expense Ratio
1.02Scheme Type
Active FundValue Research
-
Min. investment
₹1,000Minimum Additional Investment
₹1,000Minimum SIP Investment
₹10Minimum Withdrawal
₹1Exit Load
1% of applicable Net Asset Value - If the amount sought to be redeemed or switch out is invested for a period of up to 3 months from the date of allotment Nil - If the amount, sought to be redeemed or switch out is invested for a period of more than 3 months from the date of allotment1%Return Since Launch
20.71%
- 3M
- 6M
- 1Y
- 3Y
- All
Basic Details
Scheme Manager
Dhaval Shah
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 2 January 2026 | 9985.39 | -0.15% | - | -2.23% | 43/964 |
| 1 Month | 9 December 2025 | 10142.43 | 1.42% | - | 0.03% | 147/960 |
| 3 Month | 9 October 2025 | 10017.58 | 0.18% | - | 0.23% | 446/920 |
| 6 Month | 9 July 2025 | 10100.47 | 1.00% | - | 0.46% | 338/880 |
| 1 Year | 9 January 2025 | 9927.39 | -0.73% | -0.73% | 5.12% | 578/820 |
| 3 Year | 9 January 2023 | 18698.03 | 86.98% | 23.17% | 19.09% | 108/506 |
| 5 Year | 8 January 2021 | 19587.39 | 95.87% | 14.38% | 17.43% | 299/422 |
| Since Inception | 11 July 2019 | 34009.95 | 240.10% | 20.71% | 11.99% | 91/964 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 3 February 2025 | 1,20,000 | 124068.52 | 3.39% | 3.39% |
| 3 Year | 1 February 2023 | 3,60,000 | 458015.95 | 27.23% | 8.36% |
| 5 Year | 1 February 2021 | 6,00,000 | 899951.37 | 49.99% | 8.45% |
| 10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
- Investment type
- Scheme based
- SIP
- Lumpsum
Monthly Investment (₹)
Expected Returns Rate (%)
Time Period (in Years)
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
4.58%
Standard Deviation
0.90%
Beta
1.04%
Sharpe Ratio
-0.04%
Treynor's Ratio
10.87%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Sun Pharma.Inds. | 13.47% | 656076 | 112.83 | Equity | Pharmaceuticals |
| Apollo Hospitals | 7.14% | 84936 | 59.82 | Equity | Healthcare |
| Cipla | 6.08% | 337098 | 50.95 | Equity | Pharmaceuticals |
| Torrent Pharma. | 4.71% | 102446 | 39.44 | Equity | Pharmaceuticals |
| J B Chemicals & | 4.51% | 207484 | 37.76 | Equity | Pharmaceuticals |
| Abbott India | 4.48% | 12933 | 37.54 | Equity | Pharmaceuticals |
| Ajanta Pharma | 4.28% | 129312 | 35.81 | Equity | Pharmaceuticals |
| Aurobindo Pharma | 4.11% | 291254 | 34.46 | Equity | Pharmaceuticals |
| Fortis Health. | 3.99% | 377564 | 33.38 | Equity | Healthcare |
| Lupin | 3.94% | 156214 | 32.95 | Equity | Pharmaceuticals |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| Aditya Birla SL Pharma & Healthcare Fund - Dir (G) | 853.63 | 1.42% | 0.18% | 1.00% | -0.73% | 23.17% | |
| Nippon India Taiwan Equity Fund - Direct (G) | 423.45 | 2.02% | 8.69% | 35.31% | 52.76% | 38.82% | |
| Nippon India Taiwan Equity Fund - Direct (IDCW) | 423.45 | 2.02% | 8.69% | 35.31% | 52.76% | 38.82% | |
| Aditya Birla SL International Equity Fund - Direct (G) | 273.54 | 2.57% | 4.32% | 15.95% | 38.54% | 17.15% | |
| Aditya Birla SL International Equity Fund - Direct (IDCW) | 273.54 | 2.57% | 4.32% | 15.95% | 38.54% | 17.15% | |
| Franklin Asian Equity Fund - Direct (G) | 297.29 | 5.06% | 6.91% | 20.45% | 30.83% | 12.56% |
List of Schemes under Aditya Birla Sun Life Mutual Fund
News
Aditya Birla Sun Life Mutual Fund announces change in Key Personnel
Aditya Birla Sun Life Mutual Fund has been announced that Ms. Sneha Suhas will be appointed as Key Personnel in the capacity of Chief Technology Officer with effect from Thursday, January 8, 2026:Details of Ms. Sneha Suhas
Age: 55 years
Designation: Chief Technology Officer
Qualification: B.E. in Computer Engineering, MBA in IT & Systems
Powered by Capital Market - Live News
Aditya Birla Sun Life Mutual Fund announces change in fund manager under its schemes
Aditya Birla Sun Life Mutual Fund has announced change in fund manager under the following schemes, With effect from 07 January 2026.Change in Fund Manager:
Scheme Name Existing Fund Manager(s) New Fund Manager(s) Aditya Birla Sun Life Large Cap Fund Mr. Mahesh Patil Mr. Harish Krishnan Aditya Birla Sun Life Infrastructure Fund Mr. Mahesh Patil and
Mr. Jonas BhuttaMr. Jonas Bhutta Powered by Capital Market - Live News
Aditya Birla Sun Life MF announces Income Distribution cum Capital Withdrawal (IDCW) under its scheme
Aditya Birla Sun Life Mutual Fund has announced 01 January 2026 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) on the face value of Rs 10 per unit under the following scheme:Aditya Birla Sun Life Dynamic Bond Fund:
Regular Plan ' IDCW Quarterly Option: Rs 0.1483 per unit.
Direct Plan ' IDCW Quarterly Option: Rs 0.1520 per unit.
Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
20 June 2019
Total AUM (Cr)
₹837.41
Aditya Birla SL Pharma & Healthcare Fund - Dir (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, Aditya Birla Sun Life Mutual Fund. Launched in 20 June 2019, this fund is managed by Dhaval Shah. With assets under management (AUM) worth ₹837.41 (Cr), as of 9 January 2026, Aditya Birla SL Pharma & Healthcare Fund - Dir (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 20.71% since its launch.
The current NAV of Aditya Birla SL Pharma & Healthcare Fund - Dir (G) is ₹34.18, as on 9 January 2026. The fund's benchmark index is BSE Healthcare TRI. You can invest in Aditya Birla SL Pharma & Healthcare Fund - Dir (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹10 while the minimum lumpsum investment is ₹1,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
The fund has generated 23.17% and 14.38% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 98.81% in Equity, 1.36% in Debt and -0.17% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 73.46% in Pharmaceuticals & Biotech, 22.25% in Healthcare Services, 1.90% in Debt, 1.64% in Insurance, 0.99% in Chemicals & Petrochemical
